Observational studyPigment cell & melanoma research2025

Impact of Drug-Drug Interactions on Clinical Outcomes in Metastatic Melanoma Patients Treated With Combined BRAF/MEK Inhibitors: A Real-World Study.

Silvia Mezi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.